Navigation Links
Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants

tely 27,000 people in 17 countries and regions worldwide. Otsuka and its consolidated subsidiaries earned US $6.8 billion in consolidated annual revenues in fiscal 2005.

Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.

                  Visit Bristol-Myers Squibb at: www.bms.com

       Visit Otsuka Pharmaceutical Co., Ltd. at: www.otsuka-global.com

Forward Looking Statement

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995, regarding product development. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. There can be no guarantee that a registrational submission will be made to the FDA based on the data described in this press release or if such registrational submission is made, that it would receive FDA approval. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect Bristol- Myers Squibb's business, particularly those identified in the cautionary factors discussion in Bristol-Myers Squibb's Annual Report on Form 10-K for the year ended December 31, 2006 and in our Quarterly Reports on Form 10-Q. Bristol-Myers Squibb undertakes no obligation to publicly update any forward- looking statement, whether as a result of new information, future events or otherwise.

   References


    (1) Berman RM, Marcus RN, Swanink R, Carson Jr WH, McQuade RD, Khan A.

        Efficacy and safety of aripiprazole as adjunctive therapy
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
(Date:9/19/2014)... Mass. , Sept. 19, 2014  Alere Inc. ... rapid diagnostics, issued the following statement today in support ... Antibiotic-Resistant Bacteria. "As the global leader in ... for establishing a national strategy to address the serious ... to work with the Administration on initiatives to promote ...
(Date:9/19/2014)... 19, 2014  Lpath, Inc. (NASDAQ: ... therapeutics, announced today that it has entered into ... common stock and 3,605,042 unregistered warrants in a ... one registered share of common stock and one ... common stock will be $3.475.  The warrants have ...
(Date:9/19/2014)... , Sept. 19, 2014  The body of ... the publication of two papers this past week.  The ... Head and Neck Surgery , finds that withholding ... subjective measures of sleep disordered breathing, leading the paper,s ... in obstructive sleep apnea severity and improvement of quality ...
Breaking Medicine Technology:Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4
... BEDFORD, Mass., Dec. 3 MicroCHIPS, a developer of ... named a 2010 Technology Pioneer by the World Economic ... pioneering a novel medical device platform that uses patented, ... monitoring and treatment. MicroCHIPS, technologies have broad applicability, ...
... , MAPLE GROVE, Minn., Dec. 3 ... its strategic plan for central nervous system (CNS) diseases with ... management of epilepsy. USL255 is being developed with Upsher-Smith,s proprietary ... in early 2010 for the adjunctive treatment of epilepsy patients ...
Cached Medicine Technology:MicroCHIPS Named 2010 Technology Pioneer by World Economic Forum 2Upsher-Smith Announces Milestone in Development of CNS Strategy 2
(Date:9/21/2014)... 21, 2014 "I wanted to be ... to consume sugary, foul-tasting energy drinks," said an inventor ... just want to drink plain, old coffee. That is ... , He developed ENERG CHEWING GUM to provide a ... loss. The formula contains nutritious vitamins, minerals and antioxidants. ...
(Date:9/21/2014)... why cancer cells metastasize? Think of Sparta. , Ancient ... prepared them for the demands of battle on distant ... thing according to a new study revealing previously unknown ... the original tumor site, and those that travel to ... ability to metastasize is the primary cause of cancer-related ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 "I want ... legs and back but haven’t the money for chiropractors," ... like to have such a product for myself." , ... way to stretch the thigh muscles and align the ... well as relieves discomfort of pinched nerves. Compact and ...
(Date:9/21/2014)... 2014 The Electronic Medical Records ... electronic medical records (EMR) and electronic health records ... legislation during the past five years and is ... five years to 2019. The 2009 Health Information ... Medicare and Medicaid incentives to encourage the widespread ...
(Date:9/21/2014)... Best Cheap Hosting USA, one of the ... and GreenGeeks are the best Reseller hosting suppliers in ... hosting supplier. Actually, these companies have outperformed their competitors ... People can get the best web hosting at affordable ... to the manager, reseller hosting is a very popular ...
Breaking Medicine News(10 mins):Health News:Cancer cells adapt energy needs to spread illness to other organs 2Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 4Health News:Best Cheap Hosting USA Announces The Best Reseller Hosting Suppliers In 2014 2
... , More than 3 million people have texted " ... , WASHINGTON , Feb. 11 ... to the American Red Cross Haiti Relief and Development Fund by sending the ... in mobile giving for the ongoing relief efforts. , (Logo:   http://www.newscom.com/cgi-bin/prnh/20090108/RedCrossLOGO ) ...
... University of Georgia Influenza Pathogenesis and Immunology Research Center ... at the Emory Conference Center featuring an international roster ... Pandemic of the 21st Century" will feature leading investigators ... Fauci, director of the National Institute of Allergy and ...
... ... continuing-education requirements with convenient and affordable online courses that are peer reviewed and New ... ... career information resource and social networking Web site for physical therapy professionals ...
... , , OAKLAND, Calif. , Feb. ... health care providers and nonprofit health plans, announced today it approved ... the fourth quarter of 2009. In total, Kaiser Permanente approved ... keep people healthy during these tough economic times.   , "We ...
... , , WESTPORT, Conn. , ... by Westport resident and Zeta Interactive CEO, Al ... Laughter" fundraiser event this evening from Aitoro,s Appliances in Norwalk, ... Angels event in 2010, will feature live entertainment and dancing, top-quality ...
... , , CLEVELAND , Feb. 11 ... healthcare,s most distinguished thought leaders and experts on healthcare reform to ... for their Annual Forum entitled "Reform + Evolution = Revolution". , ... to challenges this coming year.  The Keynote Speaker, Dr. Mark ...
Cached Medicine News:Health News:Red Cross Raises More Than $32 Million Via Mobile Giving Program 2Health News:Red Cross Raises More Than $32 Million Via Mobile Giving Program 3Health News:Red Cross Raises More Than $32 Million Via Mobile Giving Program 4Health News:Red Cross Raises More Than $32 Million Via Mobile Giving Program 5Health News:Red Cross Raises More Than $32 Million Via Mobile Giving Program 6Health News:DavisPTnetwork Partners with the New York Physical Therapy Association to Provide Online Continuing Education 2Health News:Kaiser Permanente Approves $170 Million in Community Benefit Grants in 2009 2Health News:Kaiser Permanente Approves $170 Million in Community Benefit Grants in 2009 3Health News:Kaiser Permanente Approves $170 Million in Community Benefit Grants in 2009 4Health News:Kaiser Permanente Approves $170 Million in Community Benefit Grants in 2009 5Health News:Al's Angels' 'Love and Laughter' Event to Support Children and Families in Desperate Need 2Health News:Al's Angels' 'Love and Laughter' Event to Support Children and Families in Desperate Need 3Health News:Health Care Reform Thought Leaders to Meet in March 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: